3SBio Inc  

(Public, NASDAQ:SSRX)   Watch this stock  
Find more results for SSRX
16.59
May 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 10.15 - 16.70
Open     -
Vol / Avg. 0.00/149,084.00
Mkt cap 366.10M
P/E 22.58
Div/yield     -
EPS 0.73
Shares     -
Beta 1.46
Inst. own     -

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 22.22% 31.45%
Operating margin 33.38% 36.49%
EBITD margin - 32.38%
Return on average assets 6.60% 11.78%
Return on average equity 9.93% 16.05%
Employees 3,305 -
CDP Score - -

Address

No. 3 A1, Road 10 Shenyang Economy & Technology Development Zone
SHENYANG, LIA 110027
China
+86-24-25811820 (Phone)
+86-24-25811821 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

3SBio Inc. is an investment holding company, principally engaged in the development, production, marketing and sale of pharmaceutical products in Mainland China. The Company’s subsidiaries include Collected Mind Limited, Hongkong Sansheng Medical Limited and Shenyang Sunshine Pharmaceutical Co., Ltd.. Through its subsidiaries, the Company is engaged in project management and consultation.

Officers and directors

Jing Lou Executive Chairman of the Board, Chief Executive Officer
Age: 53
Bo Tan Chief Financial Officer, Executive Vice President, Executive Director
Age: 43
Yongfu Chen Director - Finance
Age: 59
Fei You Director - Finance
Age: 37
Junlin Wang President - Guojian
Weihonghas Xiao Chief Operating Officer
Age: 47
Dongmei Su Senior Vice President, Executive Director
Age: 45
Zhenping Zhu MD. Ph.D. Chief Scientific Officer, President - Research & Development
Bin Huang Vice President, Executive Director
Age: 55
Xin Ma Vice President - Human Resources
Age: 55